Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Development of a transcallosal tractography template and its application to dementia.

Archer DB, Coombes SA, McFarland NR, DeKosky ST, Vaillancourt DE.

Neuroimage. 2019 Jun 28;200:302-312. doi: 10.1016/j.neuroimage.2019.06.065. [Epub ahead of print]

PMID:
31260838
2.

Better Brain and Cognition Prior to Surgery Is Associated With Elevated Postoperative Brain Extracellular Free-Water in Older Adults.

Tanner JJ, Amin M, Hardcastle C, Parvataneni H, Vaillancourt DE, Mareci TH, Price CC.

Front Aging Neurosci. 2019 May 16;11:117. doi: 10.3389/fnagi.2019.00117. eCollection 2019.

3.

Types of errors on a semantic interference task in mild cognitive impairment and dementia.

Torres VL, Rosselli M, Loewenstein DA, Curiel RE, Vélez Uribe I, Lang M, Arruda F, Penate A, Vaillancourt DE, Greig MT, Barker WW, Bauer RM, Duara R.

Neuropsychology. 2019 Jul;33(5):670-684. doi: 10.1037/neu0000542. Epub 2019 May 9.

PMID:
31070384
4.

Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity.

Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, Rosselli M, Penate A, Shea YF, Behar R, Ollarves A, Robayo C, Hanson K, Marsiske M, Burke S, Ertekin-Taner N, Vaillancourt D, De Santi S, Golde T, St D.

Neuroimage Clin. 2019;22:101800. doi: 10.1016/j.nicl.2019.101800. Epub 2019 Mar 27.

5.

Network-level connectivity is a critical feature distinguishing dystonic tremor and essential tremor.

DeSimone JC, Archer DB, Vaillancourt DE, Wagle Shukla A.

Brain. 2019 Jun 1;142(6):1644-1659. doi: 10.1093/brain/awz085.

PMID:
30957839
6.

Multimodal dopaminergic and free-water imaging in Parkinson's disease.

Yang J, Archer DB, Burciu RG, Müller MLTM, Roy A, Ofori E, Bohnen NI, Albin RL, Vaillancourt DE.

Parkinsonism Relat Disord. 2019 May;62:10-15. doi: 10.1016/j.parkreldis.2019.01.007. Epub 2019 Jan 6.

PMID:
30639168
7.

Imaging Markers of Progression in Parkinson's Disease.

Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S; IPMDS‐Neuroimaging Study Group.

Mov Disord Clin Pract. 2018 Oct 9;5(6):586-596. doi: 10.1002/mdc3.12673. eCollection 2018 Nov-Dec. Review.

PMID:
30637278
8.

The Future of Brain Imaging in Parkinson's Disease.

Helmich RC, Vaillancourt DE, Brooks DJ.

J Parkinsons Dis. 2018;8(s1):S47-S51. doi: 10.3233/JPD-181482.

9.

Cortical dynamics within and between parietal and motor cortex in essential tremor.

Roy A, Coombes SA, Chung JW, Archer DB, Okun MS, Hess CW, Wagle Shukla A, Vaillancourt DE.

Mov Disord. 2019 Jan;34(1):95-104. doi: 10.1002/mds.27522. Epub 2018 Oct 21.

PMID:
30345712
10.

Illuminating basal ganglia and beyond in Parkinson's disease.

Vaillancourt DE, Lehericy S.

Mov Disord. 2018 Sep;33(9):1373-1375. doi: 10.1002/mds.27483. No abstract available.

11.

Imaging of Motor Cortex Physiology in Parkinson's Disease.

Burciu RG, Vaillancourt DE.

Mov Disord. 2018 Nov;33(11):1688-1699. doi: 10.1002/mds.102. Epub 2018 Oct 2. Review.

12.

Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Yang J, Burciu RG, Vaillancourt DE.

Curr Neurol Neurosci Rep. 2018 Oct 2;18(12):83. doi: 10.1007/s11910-018-0894-7. Review.

PMID:
30280267
13.

Finding useful biomarkers for Parkinson's disease.

Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, Gwinn K, Huang X, Kopil C, Kremer T, Lasch S, Marek K, Marto JA, Merchant K, Mollenhauer B, Naito A, Potashkin J, Reimer A, Rosenthal LS, Saunders-Pullman R, Scherzer CR, Sherer T, Singleton A, Sutherland M, Thiele I, van der Brug M, Van Keuren-Jensen K, Vaillancourt D, Walt D, West A, Zhang J.

Sci Transl Med. 2018 Aug 15;10(454). pii: eaam6003. doi: 10.1126/scitranslmed.aam6003. Review.

PMID:
30111645
14.

Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.

Chung JW, Burciu RG, Ofori E, Coombes SA, Christou EA, Okun MS, Hess CW, Vaillancourt DE.

Neuroimage Clin. 2018 May 18;19:559-571. doi: 10.1016/j.nicl.2018.05.021. eCollection 2018.

15.

Reply: Visually-sensitive networks in essential tremor: evidence from structural and functional imaging.

Archer DB, Coombes SA, Chu WT, Woo Chung J, Burciu RG, Okun MS, Wagle Shukla A, Vaillancourt DE.

Brain. 2018 Jun 1;141(6):e48. doi: 10.1093/brain/awy096. No abstract available.

16.

Genetic markers of dopaminergic transmission predict performance for older males but not females.

Hupfeld KE, Vaillancourt DE, Seidler RD.

Neurobiol Aging. 2018 Jun;66:180.e11-180.e21. doi: 10.1016/j.neurobiolaging.2018.02.005. Epub 2018 Feb 10.

17.

Multimodal neuroimaging and behavioral assessment of α-synuclein polymorphism rs356219 in older adults.

Burciu RG, Seidler RD, Shukla P, Nalls MA, Singleton AB, Okun MS, Vaillancourt DE.

Neurobiol Aging. 2018 Jun;66:32-39. doi: 10.1016/j.neurobiolaging.2018.02.001. Epub 2018 Feb 10.

18.

Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystonia.

Wagle Shukla A, Ostrem JL, Vaillancourt DE, Chen R, Foote KD, Okun MS.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1296-1300. doi: 10.1136/jnnp-2017-317098. Epub 2018 Jan 11.

PMID:
29326293
19.

A widespread visually-sensitive functional network relates to symptoms in essential tremor.

Archer DB, Coombes SA, Chu WT, Chung JW, Burciu RG, Okun MS, Wagle Shukla A, Vaillancourt DE.

Brain. 2018 Feb 1;141(2):472-485. doi: 10.1093/brain/awx338.

20.

The ice test to differentiate essential tremor from Parkinson's disease tremor.

Wagle Shukla A, Okun M, Vaillancourt D, Warren L.

Clin Neurophysiol. 2017 Nov;128(11):2181-2183. doi: 10.1016/j.clinph.2017.08.015. Epub 2017 Sep 8. No abstract available.

PMID:
28946133
21.

Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Almeida L, Ahmed B, Walz R, De Jesus S, Patterson A, Martinez-Ramirez D, Vaillancourt D, Bowers D, Ward H, Okun MS, McFarland NR.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):191-197. doi: 10.1002/mdc3.12382. Epub 2016 Jun 24.

22.

Progression marker of Parkinson's disease: a 4-year multi-site imaging study.

Burciu RG, Ofori E, Archer DB, Wu SS, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE.

Brain. 2017 Aug 1;140(8):2183-2192. doi: 10.1093/brain/awx146.

23.

Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.

Ofori E, Krismer F, Burciu RG, Pasternak O, McCracken JL, Lewis MM, Du G, McFarland NR, Okun MS, Poewe W, Mueller C, Gizewski ER, Schocke M, Kremser C, Li H, Huang X, Seppi K, Vaillancourt DE.

Mov Disord. 2017 Oct;32(10):1457-1464. doi: 10.1002/mds.27100. Epub 2017 Jul 17.

24.

Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia.

DeSimone JC, Pappas SS, Febo M, Burciu RG, Shukla P, Colon-Perez LM, Dauer WT, Vaillancourt DE.

Neurobiol Dis. 2017 Oct;106:124-132. doi: 10.1016/j.nbd.2017.06.015. Epub 2017 Jul 1.

25.

Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.

Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB Jr, Foroud T, German D, Huang X, Petyuk V, Potashkin JA, Saunders-Pullman R, Sutherland M, Walt DR, West AB, Zhang J, Chen-Plotkin A, Scherzer CR, Vaillancourt DE, Rosenthal LS.

Biomark Med. 2017 May;11(6):451-473. doi: 10.2217/bmm-2016-0370. Epub 2017 Jun 23.

26.

What Would Dr. James Parkinson Think Today? Tau and Other Imaging Possibilities in Parkinson's Disease.

Vaillancourt DE.

Mov Disord. 2017 Jun;32(6):805-806. doi: 10.1002/mds.27075. No abstract available.

PMID:
28597559
27.

Functional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.

Burciu RG, Hess CW, Coombes SA, Ofori E, Shukla P, Chung JW, McFarland NR, Wagle Shukla A, Okun MS, Vaillancourt DE.

Hum Brain Mapp. 2017 Sep;38(9):4563-4573. doi: 10.1002/hbm.23684. Epub 2017 Jun 8.

28.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group.

Mov Disord. 2017 Apr;32(4):510-525. doi: 10.1002/mds.26968. Epub 2017 Mar 28. Review.

PMID:
28370449
29.

Understanding Neuromuscular System Plasticity to Improve Motor Function in Health, Disease, and Injury.

Yue GH, Clark BC, Li S, Vaillancourt DE.

Neural Plast. 2017;2017:2425180. doi: 10.1155/2017/2425180. Epub 2017 Mar 2. No abstract available.

30.

A Template and Probabilistic Atlas of the Human Sensorimotor Tracts using Diffusion MRI.

Archer DB, Vaillancourt DE, Coombes SA.

Cereb Cortex. 2018 May 1;28(5):1685-1699. doi: 10.1093/cercor/bhx066.

31.

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.

Chung JW, Burciu RG, Ofori E, Shukla P, Okun MS, Hess CW, Vaillancourt DE.

Neuroimage Clin. 2017 Feb 16;14:417-421. doi: 10.1016/j.nicl.2017.02.012. eCollection 2017.

32.

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial.

Rafferty MR, Prodoehl J, Robichaud JA, David FJ, Poon C, Goelz LC, Vaillancourt DE, Kohrt WM, Comella CL, Corcos DM.

J Neurol Phys Ther. 2017 Jan;41(1):21-30.

33.

The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.

Goelz LC, David FJ, Sweeney JA, Vaillancourt DE, Poizner H, Metman LV, Corcos DM.

Exp Brain Res. 2017 Feb;235(2):615-626. doi: 10.1007/s00221-016-4830-2. Epub 2016 Nov 14.

34.

Beta-band activity and connectivity in sensorimotor and parietal cortex are important for accurate motor performance.

Chung JW, Ofori E, Misra G, Hess CW, Vaillancourt DE.

Neuroimage. 2017 Jan 1;144(Pt A):164-173. doi: 10.1016/j.neuroimage.2016.10.008. Epub 2016 Oct 14.

35.

Knowledge gaps and research recommendations for essential tremor.

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G.

Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Review.

36.

Aducanumab reduces Aβ plaques in Alzheimer's disease.

Vaillancourt DE.

Mov Disord. 2016 Nov;31(11):1631. doi: 10.1002/mds.26833. Epub 2016 Oct 14. Review. No abstract available.

PMID:
27739124
37.

Progressive resistance exercise restores some properties of the triphasic EMG pattern and improves bradykinesia: the PRET-PD randomized clinical trial.

David FJ, Robichaud JA, Vaillancourt DE, Poon C, Kohrt WM, Comella CL, Corcos DM.

J Neurophysiol. 2016 Nov 1;116(5):2298-2311. doi: 10.1152/jn.01067.2015. Epub 2016 Aug 31.

38.

Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromes.

Burciu RG, Chung JW, Shukla P, Ofori E, Li H, McFarland NR, Okun MS, Vaillancourt DE.

Neurology. 2016 Aug 16;87(7):709-17. doi: 10.1212/WNL.0000000000002985. Epub 2016 Jul 15.

39.

In vivo imaging reveals impaired connectivity across cortical and subcortical networks in a mouse model of DYT1 dystonia.

DeSimone JC, Febo M, Shukla P, Ofori E, Colon-Perez LM, Li Y, Vaillancourt DE.

Neurobiol Dis. 2016 Nov;95:35-45. doi: 10.1016/j.nbd.2016.07.005. Epub 2016 Jul 9.

40.

Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6.

Kang N, Christou EA, Burciu RG, Chung JW, DeSimone JC, Ofori E, Ashizawa T, Subramony SH, Vaillancourt DE.

Brain Struct Funct. 2017 Mar;222(2):1039-1052. doi: 10.1007/s00429-016-1263-4. Epub 2016 Jun 28.

41.

A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.

Banerjee M, Okun MS, Vaillancourt DE, Vemuri BC.

PLoS One. 2016 Jun 9;11(6):e0155764. doi: 10.1371/journal.pone.0155764. eCollection 2016.

42.

Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?

Alibiglou L, Videnovic A, Planetta PJ, Vaillancourt DE, MacKinnon CD.

Mov Disord. 2016 Nov;31(11):1711-1719. doi: 10.1002/mds.26665. Epub 2016 Jun 2.

43.

Nonlinear regression on Riemannian manifolds and its applications to Neuro-image analysis.

Banerjee M, Chakraborty R, Ofori E, Vaillancourt D, Vemuri BC.

Med Image Comput Comput Assist Interv. 2015 Oct;9349:719-727. Epub 2015 Nov 18.

44.

Free-water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO-B inhibitor.

Burciu RG, Ofori E, Shukla P, Pasternak O, Chung JW, McFarland NR, Okun MS, Vaillancourt DE.

Hum Brain Mapp. 2016 Aug;37(8):2894-903. doi: 10.1002/hbm.23213. Epub 2016 Apr 19.

45.

Free-water imaging in Parkinson's disease and atypical parkinsonism.

Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE.

Brain. 2016 Feb;139(Pt 2):495-508. doi: 10.1093/brain/awv361. Epub 2015 Dec 24.

46.

The NINDS Parkinson's disease biomarkers program.

Rosenthal LS, Drake D, Alcalay RN, Babcock D, Bowman FD, Chen-Plotkin A, Dawson TM, Dewey RB Jr, German DC, Huang X, Landin B, McAuliffe M, Petyuk VA, Scherzer CR, Hillaire-Clarke CS, Sieber BA, Sutherland M, Tarn C, West A, Vaillancourt D, Zhang J, Gwinn K; PDBP consortium.

Mov Disord. 2016 Jun;31(6):915-23. doi: 10.1002/mds.26438. Epub 2015 Oct 7.

47.

Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Wagle Shukla A, Shuster JJ, Chung JW, Vaillancourt DE, Patten C, Ostrem J, Okun MS.

PM R. 2016 Apr;8(4):356-366. doi: 10.1016/j.pmrj.2015.08.009. Epub 2015 Aug 24. Review.

48.

Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.

Burciu RG, Ofori E, Shukla P, Planetta PJ, Snyder AF, Li H, Hass CJ, Okun MS, McFarland NR, Vaillancourt DE.

Mov Disord. 2015 Aug;30(9):1248-58. doi: 10.1002/mds.26294. Epub 2015 Jul 6.

49.

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial.

David FJ, Robichaud JA, Leurgans SE, Poon C, Kohrt WM, Goldman JG, Comella CL, Vaillancourt DE, Corcos DM.

Mov Disord. 2015 Oct;30(12):1657-63. doi: 10.1002/mds.26291. Epub 2015 Jul 6.

50.

Discriminating features of gait performance in progressive supranuclear palsy.

Amano S, Skinner JW, Lee HK, Stegemöller EL, Hack N, Akbar U, Vaillancourt D, McFarland NR, Hass CJ.

Parkinsonism Relat Disord. 2015 Aug;21(8):888-93. doi: 10.1016/j.parkreldis.2015.05.017. Epub 2015 May 29.

PMID:
26032992

Supplemental Content

Loading ...
Support Center